Published in Infect Immun on December 01, 1981
Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J Clin Microbiol (1992) 1.87
Development of antibody to measles virus polypeptides during complicated and uncomplicated measles virus infections. J Virol (1984) 1.20
Antibody response to individual rubella virus proteins in congenital and other rubella virus infections. J Clin Microbiol (1985) 1.05
Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein. J Virol (1993) 0.99
Functional cDNA library for efficient expression of measles virus-specific gene products in primate cells. J Virol (1986) 0.98
Antibody response to respiratory syncytial virus structural proteins in children with acute respiratory syncytial virus infection. J Virol (1985) 0.97
Humoral and cellular immune responses to matrix protein of measles virus in subacute sclerosing panencephalitis. J Virol (1988) 0.89
Western blot analyses of measles virus antibody in normal persons and in patients with multiple sclerosis, subacute sclerosing panencephalitis, or atypical measles. J Clin Microbiol (1986) 0.82
Antibody responses to virion polypeptides in gnotobiotic dogs infected with canine distemper virus. Infect Immun (1983) 0.77
Passive hemagglutination test for measles immunity and serodiagnosis. J Clin Microbiol (1988) 0.75
Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. J Infect Dis (1975) 2.54
Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A (1979) 2.33
Appearance and persistence of antibodies against different virus components after regular measles infections. Infect Immun (1972) 2.08
The polypeptides of canine distemper virus: synthesis in infected cells and relatedness to the polypeptides of other morbilliviruses. Virology (1980) 1.69
Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus. J Immunol (1979) 1.52
Evidence for lack of synthesis of the M polypeptide of measles virus in brain cells in subacute sclerosing panencephalitis. Virology (1979) 1.48
Subacute sclerosing panencephalitis: a review. Curr Top Microbiol Immunol (1972) 1.41
Antibodies against the measles matrix polypeptide after clinical infection and vaccination. Infect Immun (1980) 1.33
Viral antibodies in multiple sclerosis. Prog Med Virol (1978) 1.27
Measles-specific antibodies in sera and cerebrospinal fluids of patients with multiple sclerosis. Infect Immun (1980) 1.22
Absence of M protein in a cell-associated subacute sclerosing panencephalitis virus. Nature (1980) 1.19
Viral and bacterial antibody responses in multiple sclerosis. Ann Neurol (1980) 1.17
Very high measles and rubella virus antibody titres associated with hepatitis, systemic lupus erythematosus, and infectious mononucleosis. Lancet (1974) 1.12
Antigenic relationships between measles and canine distemper viruses: comparison of immune response in animals and humans to individual virus-specific polypeptides. Proc Natl Acad Sci U S A (1979) 1.09
Actin filaments in paramyxovirus-infected human fibroblasts studied by indirect immunofluorescence. Arch Virol (1978) 1.02
Production of antibodies against measles virions by use of the mouse hybridoma technique. Arch Virol (1981) 1.01
Isolation and immunological characterization of the nucleocapsid and membrane proteins of measles virus. J Gen Virol (1980) 0.87
Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58
Two distinct subtypes of human respiratory syncytial virus. J Gen Virol (1985) 5.19
Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med (1996) 4.71
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc Natl Acad Sci U S A (1992) 2.98
Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med (1983) 2.91
Presence of haemagglutinin in the envelope of extracellular vaccinia virus particles. J Gen Virol (1976) 2.78
Large-quantity production of chicken embryo tracheal organ cultures and use in virus and mycoplasma studies. Appl Microbiol (1970) 2.54
Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. J Infect Dis (1975) 2.54
Elevated cord macroglobulins in the diagnosis of intrauterine infections. N Engl J Med (1966) 2.50
Respiratory syncytial virus envelope glycoprotein (G) has a novel structure. Nucleic Acids Res (1985) 2.37
Epidemic measles in young adults. Clinical, epidemiologic, and serologic studies. Ann Intern Med (1979) 2.29
Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys. Nature (1991) 2.28
Pertussis in adults. Ann Intern Med (1998) 2.25
Urban measles in the vaccine era: a clinical, epidemiologic, and serologic study. J Pediatr (1972) 2.24
Sales of nonprescription cold remedies: a unique method of influenza surveillance. Pediatr Res (1979) 2.22
DTP-associated reactions: an analysis by injection site, manufacturer, prior reactions, and dose. Pediatrics (1984) 2.15
The structural and functional diversity of Adenovirus capsid components. J Gen Virol (1969) 2.14
Structural polypeptides of measles virus. J Gen Virol (1978) 2.11
Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A (1973) 2.10
Appearance and persistence of antibodies against different virus components after regular measles infections. Infect Immun (1972) 2.08
The 'new' epidemiology of measles and rubella. Hosp Pract (1980) 2.07
Canine distemper virus from diseased large felids: biological properties and phylogenetic relationships. J Gen Virol (1996) 2.06
Adsorption and penetration of enveloped and naked vaccinia virus particles. J Virol (1978) 2.06
Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections. J Clin Microbiol (1987) 2.06
Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies. Infect Immun (1975) 2.01
The effects of monoclonal antibodies on biologic activities of structural proteins of Sendai virus. J Immunol (1982) 1.94
Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J (1994) 1.90
Monoclonal antibodies against five structural components of measles virus. I. Characterization of antigenic determinants on nine strains of measles virus. Virology (1983) 1.85
Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin Infect Dis (2000) 1.85
A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics (1998) 1.84
A search for Bordetella pertussis infection in university students. Clin Infect Dis (1992) 1.83
Identification of different measles virus-specific antibodies in the serum and cerebrospinal fluid from patients with subacute sclerosing pancencephalitis and multiple sclerosis. Infect Immun (1972) 1.82
Occurrence of respiratory syncytial virus subtypes A and B strains in Sweden. J Med Virol (1986) 1.81
The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr (1984) 1.81
Measles virus phosphoprotein retains the nucleocapsid protein in the cytoplasm. Virology (1991) 1.77
Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins. Immunol Lett (1991) 1.73
Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B. J Gen Virol (1987) 1.73
Respiratory syncytial virus fusion glycoprotein: nucleotide sequence of mRNA, identification of cleavage activation site and amino acid sequence of N-terminus of F1 subunit. Nucleic Acids Res (1985) 1.69
Pertussis in German adults. Clin Infect Dis (1995) 1.68
A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Res Hum Retroviruses (1987) 1.67
Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis. Scand J Immunol (1976) 1.66
Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation. Pediatrics (1988) 1.66
Chromosome damage associated with the measles virus in vitro. Hereditas (1965) 1.60
Discrimination between antibodies to HIV and to related retroviruses using site-directed serology. Nature (1987) 1.59
Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis (1995) 1.59
Respiratory syncytial virus epidemics: variable dominance of subgroups A and B strains among children, 1981-1986. J Infect Dis (1988) 1.58
Site-directed serology with synthetic peptides representing the large glycoprotein G of respiratory syncytial virus. Proc Natl Acad Sci U S A (1987) 1.55
'Pertussis vaccine encephalopathy': it is time to recognize it as the myth that it is. JAMA (1990) 1.55
Morphogenesis of respiratory syncytial virus in a green monkey kidney cell line (Vero). J Virol (1970) 1.53
Bacterial-viral interrelations in respiratory infections of children. N Engl J Med (1967) 1.53
Structural components of measles virus. Microbios (1972) 1.51
Five measles virus antigens demonstrated by use of mouse hybridoma antibodies in productively infected tissue culture cells. Arch Virol (1982) 1.50
Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus. J Gen Virol (1988) 1.50
The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. Am J Public Health (1997) 1.50
Antigenic structure of human respiratory syncytial virus fusion glycoprotein. J Virol (1998) 1.50
Severe reactions associated with diphtheria-tetanus-pertussis vaccine: detailed study of children with seizures, hypotonic-hyporesponsive episodes, high fevers, and persistent crying. Pediatrics (1993) 1.49
HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16. N Engl J Med (1976) 1.49
Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis. Infect Immun (1974) 1.48
Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immunocompromised child. Am J Epidemiol (1984) 1.47
Proposal for genetic characterisation of wild-type mumps strains: preliminary standardisation of the nomenclature. Arch Virol (2005) 1.45
Structural differences between subtype A and B strains of respiratory syncytial virus. J Gen Virol (1986) 1.45
Measles virus antibodies in multiple sclerosis. Comparison of antibody titers in cerebrospinal fluid and serum. Arch Neurol (1974) 1.44
Cerebral vasculopathy associated with primary varicella infection. Arch Neurol (1990) 1.44
Paramyxovirus SV5 and multiple sclerosis. Nature (1989) 1.43
The viral association of neonatal cholestasis in Sweden: a possible link between cytomegalovirus infection and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr (1998) 1.43
Erythema migrans after ceftriaxone treatment of aseptic meningitis caused by Borrelia burgdorferi. Pediatr Infect Dis J (2001) 1.43
[Lumbar disk prolapses and radiological spinal intervention. What do the randomized controlled trials say?]. Tidsskr Nor Laegeforen (1998) 1.42
A carrier cell line of measles virus in Lu 106 cells. Arch Gesamte Virusforsch (1967) 1.41
Acute fever and petechial rash associated with influenza A virus infection. Clin Infect Dis (1999) 1.41
Immunological relationships between homologous structural polypeptides of measles and canine distemper virus. J Gen Virol (1980) 1.40
Mycoplasma pneumoniae infections and exanthems. J Pediatr (1975) 1.39
Immunologic properties of purified Sendai virus glycoproteins. J Immunol (1977) 1.39
The effect of a carbobenzoxy tripeptide on the biological activities of measles virus. Virology (1971) 1.38
The relationship between the soluble antigens and the virion of adenovirus type 3. I. Morphological characteristics. Virology (1966) 1.36
Household contact study of Bordetella pertussis infections. Clin Infect Dis (1995) 1.35
Persistence of RNA viruses in the central nervous system. Annu Rev Microbiol (1986) 1.33
IgG1 subclass restriction of oligoclonal IgG from cerebrospinal fluids and brain extracts in patients with multiple sclerosis and subacute encephalitides. Scand J Immunol (1976) 1.33
The evaluation of racemic epinephrine in the treatment of infectious croup. Pediatrics (1973) 1.33
Serum antibody responses to individual viral polypeptides in human rotavirus infections. J Gen Virol (1987) 1.31
Improved method for collection of nasal mucus. J Infect Dis (1977) 1.31
Hemorrhage from cecal ulcers of cytomegalovirus infection: report of a case. Ann Surg (1973) 1.30
Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine (2001) 1.29
Bordetella pertussis infections and sudden unexpected deaths in children. Eur J Pediatr (1996) 1.29
Cerebrospinal fluid and serum immunoglobulins and antibody titers in mumps meningitis and aseptic meningitis of other etiology. Infect Immun (1978) 1.28
Respiratory syncytial virus: heterogeneity of subgroup B strains. J Gen Virol (1988) 1.27
Viral antibodies in multiple sclerosis. Prog Med Virol (1978) 1.27
Therapy of Haemophilus influenzae meningitis reconsidered. N Engl J Med (1972) 1.27
Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis. Pediatr Infect Dis J (1995) 1.26
Immunological and other biological characteristics of pentons of human adenoviruses. J Virol (1969) 1.26